NCT02628769View on ClinicalTrials.gov

A Study to Evaluate the Anti-inflammatory Effects of Solithromycin in Chronic Obstructive Pulmonary Disease

PHASE2TerminatedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

January 5, 2017

Study Completion Date

January 5, 2017

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

Solithromycin

DRUG

Placebo

Trial Locations (1)

UB9 6JH

Muscle Lab, Respiratory Medicine, Harefield Hospital, Harefield

Sponsors
All Listed Sponsors
collaborator

Melinta Therapeutics, Inc.

INDUSTRY

lead

Imperial College London

OTHER